Balentine LLC Acquires Shares of 9,893 Avantor, Inc. (NYSE:AVTR)

Posted by Defense World Staff on Apr 18th, 2023

Balentine LLC purchased a new position in shares of Avantor, Inc. (NYSE:AVTR – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 9,893 shares of the company’s stock, valued at approximately $209,000.

Other large investors also recently modified their holdings of the company. Nisa Investment Advisors LLC increased its stake in shares of Avantor by 794.5% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,120 shares of the company’s stock worth $42,000 after purchasing an additional 1,883 shares during the last quarter. Alta Advisers Ltd purchased a new stake in shares of Avantor during the 3rd quarter worth approximately $47,000. TFC Financial Management purchased a new stake in shares of Avantor during the 3rd quarter worth approximately $51,000. Signaturefd LLC increased its stake in shares of Avantor by 52.4% during the 3rd quarter. Signaturefd LLC now owns 4,691 shares of the company’s stock worth $92,000 after purchasing an additional 1,612 shares during the last quarter. Finally, Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Avantor during the 3rd quarter worth approximately $110,000. Hedge funds and other institutional investors own 88.80% of the company’s stock.

Avantor Stock Up 2.4 %

Shares of NYSE:AVTR opened at $21.19 on Tuesday. Avantor, Inc. has a 52-week low of $17.91 and a 52-week high of $34.37. The firm has a fifty day moving average of $22.55 and a 200 day moving average of $21.67. The firm has a market capitalization of $14.29 billion, a PE ratio of 20.77 and a beta of 1.34. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.05 and a current ratio of 1.60.

Avantor (NYSE:AVTR – Get Rating) last announced its earnings results on Friday, February 3rd. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.02. Avantor had a net margin of 9.14% and a return on equity of 22.06%. The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.79 billion. During the same period in the previous year, the business earned $0.36 earnings per share. The firm’s quarterly revenue was down 5.9% compared to the same quarter last year. As a group, research analysts anticipate that Avantor, Inc. will post 1.39 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Christophe Couturier sold 1,498 shares of the company’s stock in a transaction on Tuesday, April 11th. The shares were sold at an average price of $21.18, for a total value of $31,727.64. Following the completion of the transaction, the executive vice president now directly owns 98,650 shares in the company, valued at $2,089,407. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Avantor news, EVP Christophe Couturier sold 1,498 shares of the company’s stock in a transaction dated Tuesday, April 11th. The shares were sold at an average price of $21.18, for a total transaction of $31,727.64. Following the completion of the sale, the executive vice president now directly owns 98,650 shares in the company, valued at $2,089,407. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Gerard Brophy sold 11,339 shares of the company’s stock in a transaction dated Thursday, February 2nd. The shares were sold at an average price of $25.06, for a total transaction of $284,155.34. Following the sale, the executive vice president now owns 102,385 shares of the company’s stock, valued at $2,565,768.10. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 19,829 shares of company stock worth $488,344. Corporate insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Wells Fargo & Company raised their price target on shares of Avantor from $25.00 to $28.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 8th. Raymond James lifted their price objective on shares of Avantor from $26.00 to $30.00 and gave the company an “outperform” rating in a research note on Monday, February 6th. Robert W. Baird reduced their price objective on shares of Avantor from $29.00 to $27.00 in a research note on Monday, February 6th. Citigroup lifted their price objective on shares of Avantor from $25.00 to $30.00 and gave the company a “buy” rating in a research note on Monday, February 6th. Finally, Barclays reduced their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, April 4th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, Avantor presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.27.

About Avantor

(Get Rating)

Avantor, Inc engages in providing mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The firm operates through the following segments: the Americas, Europe, and AMEA.

Balentine LLC Acquires Shares of 9,893 Avantor, Inc. (NYSE:AVTR)

Avantor Stock Up 2.4 %

Insider Buying and Selling

Wall Street Analyst Weigh In

About Avantor

Recommended Stories

You might be interested in: